{"schema_version":"secwatch.filing_event.v1","accession":"0000818479-22-000089","form_type":"8-K","ticker":"XRAY","cik":"0000818479","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2022-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.219464+00:00","generated_at":"2026-06-23T21:32:37.675410+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Dentsply Sirona appoints Simon Campion (ex-BD) as CEO, effective Sept 12, 2022","bullets":["Simon Campion appointed President & CEO, effective Sept 12, 2022; succeeds interim CEO John Groetelaars who remains on Board.","Campion previously EVP & President of BD Medical segment; held leadership roles at BD and C.R. Bard.","Board requests full review of business operations including competitive positioning, margin enhancement, and capital structure.","Employment agreement: $1M base salary, 125% target bonus, $7M equity make-whole grant, annual LTI of at least $5M starting FY2023.","Ongoing Audit Committee review mentioned; new CEO to lead after completion."],"urls":{"canonical":"https://secwatch.observer/filing/0000818479-22-000089","json":"https://secwatch.observer/filing/0000818479-22-000089.json","markdown":"https://secwatch.observer/filing/0000818479-22-000089.md","text":"https://secwatch.observer/filing/0000818479-22-000089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000089/0000818479-22-000089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000089/xray-20220822.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T21:32:37.675410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"55be85501b","claim":"John P. Groetelaars changed role as Interim Chief Executive Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"As of the Effective Date, Mr. Campion will succeed John P. Groetelaars, who has served as Interim Chief Executive Officer since April 16, 2022, and Mr. Groetelaars will continue as a non-executive director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000089/0000818479-22-000089-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"succeeded"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"b7dbb9d4b3","claim":"Simon D. Campion was appointed as President and Chief Executive Officer at DENTSPLY SIRONA Inc..","evidence_excerpt":"On August 22, 2022, DENTSPLY SIRONA Inc. (the “Company”) appointed Simon D. Campion as the President and Chief Executive Officer of the Company and as a member of the Company’s Board of Directors (the “Board”), in each case effective as of September 12, 2022, or such other date as mutually agreed between the Company and Mr. Campion (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847922000089/0000818479-22-000089-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}